Ysbyty Glan Clwyd’s Haematology and Research teams commended for work on Acute Myeloid Leukaemia

The Haematology and Research teams at Ysbyty Glan Clwyd, Rhyl, have been named runners up in a prestigious national award which recognised their efforts in the field of acute myeloid leukaemia (AML) research.

Ysbyty Glan Clwyd was recognised in the National Acute Myeloid Leukaemia Trial Team of the Year Achievement Award 2023, for its high commitment to and involvement in major AML studies across the UK, whilst simultaneously working on other haemato-oncology studies such as myeloma and lymphoma trials.

There are over 80 hospitals in the UK offering treatment for AML. Although a number of larger hospitals and centres had applied for the award, Ysbyty Glan Clwyd was the only district hospital to enter.

The judging criteria took account of the teams’ involvement in National Cancer Research Institute (NCRI) AML trials, Trials Acceleration Programme (TAP) trials, and industry-sponsored research, along with involvement in future UK AML trial development, patient recruitment, local engagement with patient groups, community interaction and initiatives led by the team to improve the delivery of AML and Haemato-oncology trials.

The award panel stated that the teams had demonstrated innovative strategies to improve the delivery of AML and Haemato-oncology trials and achieved excellent trial recruitment.

Victoria Garvey, Clinical Research Specialist Nurse at Ysbyty Glan Clwyd, said: “I would like to acknowledge the research teams in Ysbyty Glan Clwyd and the wider haematology team. Without their commitment, it wouldn’t be possible to undertake these trials.”

Pictured (from left): Tori Garvey, Clinical Research Specialist Nurse; Dr Durgadevi Moratuwagama, Consultant Haematologist and Co-investigator for Haematology trials; Dr Earnest Heartin, Consultant Haematologist and PI for Haematology trials;  Zuzana Probier, Clinical Research Specialist Nurse.